MedPath

Kinematic Alignment vs Mechanical Alignment for Total Knee Arthroplasty

Not Applicable
Withdrawn
Conditions
Knee Pain Chronic
Knee Osteoarthritis
Interventions
Procedure: Mechanical Alignment and Unrestricted Kinematic Alignment using Medacta GMK Sphere with MyKnee Custom guides
Procedure: Mechanical Alignment and Restricted Kinematic Alignment using Medacta GMK Sphere with custom cutting guides
Registration Number
NCT05461638
Lead Sponsor
Medacta USA
Brief Summary

This is a prospective, randomized, single-blinded, multi-center trial comparing Kinematic Alignment vs Mechanical Alignment in TKA patients using patient reported outcomes, clinical and functional performance tests and radiographic analyses.

Detailed Description

This is a prospective, randomized, single-blinded, multi-center trial comparing Kinematic Alignment vs Mechanical Alignment in TKA patients with Medacta GMK Sphere knee system using patient specific instrumentation Medacta MyKnee. Patients will be assessed a pre-operative, operative and interim post-operative visits, week 6, month 6 and 1,2,5 \& 10 years. There will be a phone survey follow up at year 3,4,6,7,8,\& 9.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Must be able to read, understand and provide written informed consent on the Institutional Review Board (IRB) approved Informed Consent Form (ICF).

    • Ability to understand and provide written authorization for use and disclosure of personal health information.
    • Subject who are able and willing to comply with the study protocol and follow-up visits.
    • Must be 21 years or older to participate, and less than 80 years old.
    • Subjects must have osteoarthritis knee disease in the affected knee compliant with the FDA-approved indications for use of GMK Sphere knee system and MyKnee cutting blocks.
    • Patients who are candidates for Total Knee Arthroplasty and are determined to undergo a TKA using the Medacta GMK Sphere implant and MyKnee cutting blocks will be offered enrollment.
    • Subjects must be able to return for the follow-up appointments, and have the mental capacity to cooperate and complete PRO questionnaires, physical exam and radiographs.
Exclusion Criteria
  • • Cases of extreme bone loss requiring an augmented femoral or tibial implant and chronic ligamentous laxity requiring a constrained implant

    • The patient has a fixed flexion deformity of ≥15°
    • The patient has less than 90° of flexion
    • Patient is morbidly obese (BMI ≥40)
    • Patient with inflammatory arthritis
    • History of prior deep knee infection
    • History of alcoholism or drug abuse
    • Currently on chemotherapy or radiation therapy for neoplastic disease
    • Patient currently on immunosuppressive medications including steroids except when, (a) steroid use is less than 10mg daily, (b) other immunosuppressive medications are held for appropriate time, for example Adalimumab is held 2 weeks prior and 2 weeks after surgery
    • History of known sensitivity or allergy to materials used in orthopedic implants, specifically Titanium and Cobalt-Chrome alloys
    • Habitual use of narcotic pain medications prior to surgery (more than 2 doses daily and chronic use of a minimum 3 months)
    • History of metabolic disorder affecting the skeletal system other than osteoarthritis or osteoporosis (e.g., Osteomalacia, Ricketts)
    • History of chronic pain issues for reasons other than knee joint pain. If the type of pain affects activities of daily living, do not enroll. If the pain is intermittent and does not affect activities of daily living, it is OK to enroll. Fibromyalgia is exclusionary.
    • Women who are pregnant
    • Patient with unstable psychiatric illness or psychosis is excluded. (Patients with stable anxiety or depression can be enrolled if PI determines that the condition does not adversely affect study outcomes & requirements)
    • Any patient, in the opinion of the investigator, is unable to fully comply with the surgical, rehabilitation, or follow-up aspects of this procedure.
    • Prior surgery on the target knee other than arthroscopy and/or arthroscopically-assisted ligament reconstruction
    • Prior high tibial osteotomy (HTO) or femoral osteotomy
    • Malunion of fracture of a tibia or femur
    • Patient with a neuromuscular or neurosensory deficiency
    • Patient with history of knee fusion in the affected joint

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Unrestricted Kinematic AlignmentMechanical Alignment and Unrestricted Kinematic Alignment using Medacta GMK Sphere with MyKnee Custom guidesMechanical Alignment and Unrestricted Kinematic Alignment using Medacta GMK Sphere with custom cutting guides
Restricted Kinematic AlignmentMechanical Alignment and Restricted Kinematic Alignment using Medacta GMK Sphere with custom cutting guidesMechanical Alignment and restricted Kinematic Alignment using Medacta GMK Sphere with custom cutting guides
Primary Outcome Measures
NameTimeMethod
Change from baseline in Forgotten Joint ScorePost operative 4-132 months

Assessment of the improvement of joint specific outcomes following knee replacement surgery using the Knee Forgotten Joint Score

Secondary Outcome Measures
NameTimeMethod
Change from baseline in Knee Osteoarthritis Outcome Score (KOOS)Baseline to Post operative 4-132 months

Assessment of improvement of activity levels following knee replacement surgery using the KOOS

Change from baseline in Knee Society ScoreBaseline to Post operative 4-132 months

Clinical Exam Range of Motion, Stability and Alignment

Change in Baseline in Knee AlignmentBaseline to Post operative 4-132 months

Determined by radiographic analysis measured by angle of degrees

Change from baseline in PROMISBaseline to Post operative 4-132 months

Pain Intensity, Pain Interference, and physical function scoring

Change from Baseline of Implant Position FixationBaseline to Post operative 4-132 months

Determined by radiographic analysis by measure radio lucent lines in millimeters

© Copyright 2025. All Rights Reserved by MedPath